Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from the CAGI-4 Hopkins clinical panel challenge.

John-Marc Chandonia1, Aashish Adhikari2, Marco Carraro3

  • 1Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, California.

Human Mutation
|April 12, 2017
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-Based Design, Synthesis, and Evaluation of Novel Ponatinib Derivatives With a Significantly Altered Selectivity Profile.

ChemMedChem·2026
Same author

On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases.

Journal of medicinal chemistry·2026
Same author

p21-Activated Kinase (PAK) Group I-Targeting Inhibitors Promote the Dimeric Conformation in Live Cells.

ACS chemical biology·2026
Same author

The "one-and-a-half" minimally invasive transforaminal lumbar interbody fusion: a single-center retrospective case series.

Journal of neurosurgery. Spine·2026
Same author

First Structure-Activity-Relationship Study of Potent G2A Antagonists.

Journal of medicinal chemistry·2026
Same author

Predictors of deep brain stimulation response in patients with obsessive compulsive disorder: a systematic review and meta-analysis.

Scientific reports·2026
Same journal

COL1A1 and SERPINE1 as Potential Therapeutic Targets in Diabetic Retinopathy: A Study Incorporating RNA Transcriptomics, Single-Cell RNA Sequencing, and Proteomics.

Human mutation·2026
Same journal

Autosomal Dominant Missense <i>DAG1</i> Variant Linked to Mild-Moderate LGMD R16.

Human mutation·2026
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026
See all related articles
Summary
This summary is machine-generated.

The CAGI-4 challenge evaluated DNA sequence analysis for predicting disease. Advanced methods accurately identified disease classes, even when the lab found no variants, improving clinical genetic diagnostics.

Area of Science:

  • Genomics
  • Clinical Diagnostics
  • Bioinformatics

Background:

  • Assessing the accuracy of clinical phenotype prediction from DNA sequence is crucial for genetic diagnostics.
  • The Johns Hopkins DNA Diagnostic Laboratory provided patient exonic sequences for this evaluation.
  • Existing diagnostic methods may miss clinically relevant variants, especially with targeted gene panels.

Purpose of the Study:

  • To evaluate state-of-the-art methods for clinical phenotype prediction using DNA sequence data.
  • To assess the performance of different prediction groups in identifying disease classes and causal variants.
  • To understand the implications for assessing variants of unknown significance and the false-positive rate of DNA-guided analysis.

Main Methods:

  • Participants analyzed exonic sequences of 83 genes from 106 patients.
Keywords:
CAGIgenetic testingphenotype predictionvariant interpretation

Related Experiment Videos

  • Five groups predicted disease class probabilities and causal variants.
  • Performance was evaluated against diagnoses from the Johns Hopkins DNA Diagnostic Laboratory.

    • Main Results:

    • At least one predictor correctly identified the disease class in 84% of patients with reported variants (36/43).
    • Predictors achieved 62% accuracy (39/63) even when the lab did not find a variant.
    • Each group uniquely diagnosed at least one patient, highlighting complementary diagnostic capabilities.

    Conclusions:

    • Computational methods show promise for clinical phenotype prediction from DNA sequence.
    • Targeted gene panels may lead to missed diagnoses; broader analysis could be beneficial.
    • The study quantifies the false-positive rate in DNA-guided analysis without prior phenotypic information.